Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that CEO Joseph Oliveto will present at several upcoming investor conferences. Key events include the Cowen 41st Annual Health Care Conference on March 4, 2021, the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, and the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021. A replay of the H.C. Wainwright presentation and a live webcast of the Oppenheimer presentation will be available on their website. Milestone focuses on developing etripamil for cardiovascular treatment.

MONTREAL and CHARLOTTE, N.C., Feb. 25, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

• The Cowen 41^st Annual Health Care Conference's panel on Cardiovascular Disease and Hospital Products on Thursday, March 4, 2021 at 1:30 p.m. Eastern Time.
• The H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021 on demand beginning at 7:00 a.m. Eastern Time.
• The Oppenheimer 31^st Annual Healthcare Conference on Tuesday, March 16, 2021 at 10:00 a.m. Eastern Time.

A replay of the pre-recorded H.C. Wainwright presentation and live webcast Oppenheimer presentation can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcasts will be available on the same website for approximately 90 days following the presentations.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma. 

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301235125.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

What presentations will Milestone Pharmaceuticals (MIST) CEO Joseph Oliveto give?

Joseph Oliveto will present at the Cowen 41st Annual Health Care Conference on March 4, 2021, the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, and the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021.

When is the Cowen Health Care Conference featuring Milestone Pharmaceuticals (MIST)?

The Cowen 41st Annual Health Care Conference will take place on March 4, 2021, at 1:30 p.m. Eastern Time.

How can I access the Milestone Pharmaceuticals (MIST) conference presentations?

The replay of the H.C. Wainwright presentation and the live webcast of the Oppenheimer presentation can be accessed on Milestone's website in the News & Events section.

What is the focus of Milestone Pharmaceuticals (MIST)?

Milestone Pharmaceuticals is focused on the development and commercialization of etripamil, a drug for cardiovascular indications.

Where does Milestone Pharmaceuticals (MIST) operate?

Milestone Pharmaceuticals operates in Canada and the United States.